Prakt. lékáren. 2016; 12(3): 111-117 | DOI: 10.36290/lek.2016.026
Over-the-counter medications in treatment of the benign prostatic hyperplasia
- Oddělení klinické farmacie a Lékové informační centrum, Ústavní lékárna IKEM, Praha
Benign prostatic hyperplasia among benign, but if not treated, progressive, disease significantly affecting the quality of life of
men after the 40th year of life. With age the incidence of this disease is increasing.
Article aims to inform the reader with currently available products intended for self-medication syndrome of the lower urinary
tract, thus clinically expressed symptoms of benign prostatic hyperplasia. These are mainly phytopharmaceuticals containing
mostly extract from the fruit of the weed dwarf palm Serenoa repens.
In addition to the list of trade names of OTC preparations, their composition and recommended dosages are the article contains
a brief description of selected components of pharmaceuticals.
Keywords: benign prostatic hyperplasia, lower urinary tract syndrome, phytopharmaceuticals, self-medication, over-the-counter
Published: July 1, 2016 Show citation
References
- Hanuš M. Benigní hyperplazie prostaty. In: Abrahámová J. Doporučený postup pro léčbu vybraných urologických onemocnění: doporučený diagnostický a léčebný postup pro všeobecné praktické lékaře 2011, Společnost všeobecného lékařství 2011: 3-6.
- Rudolf K. Farmaceutická péče u pacientů s benigní hyperplazií prostaty. Prakt. lékáren. 2012; 8(4): 177-180.
- Juliao AA, Plata M, Kazzazi A, Bostanci Y, Djavan B. American Urological Association and European Association of Urology guidelines in the management of benign prostatic hypertrophy: revisited. Curr Opin Urol. 2012; 22(1): 34-39.
Go to original source... 
Go to PubMed... - Wilt TJ, Ishani A, Rutks I, MacDonald R. Phytotherapy for benign prostatic hyperplasia. Public Health Nutr. 2000; 3(4A): 459-472. Go to original source... Go to PubMed...
- Tacklind J, MacDonald R, Rutks I, Stanke JU, Wilt TL. Serenoa repens for benign prostatic hyperplasia. Cochrane Summaries, published online 12 December 2012. Go to original source... Go to PubMed...
- Mills S, Bone K. The Essential Guide to Herbal Safety, Elsevi-er Churchill Livingstone, Missouri, 2005: 560-562.
- Yue Q-Y, Jansson K. Herbal drug curbicin and anticoagulant effect with and without warfarin: possibly related to the vitamin E component. J Am Geriatr Soc 2001; 49(6): 838. Go to original source... Go to PubMed...
- Wilt TJ, Ishani A, MD, Stark G, MacDonald R, Lau J, Mulrow C. Pygeum africanum for benign prostatic hyperplasia. Cochrane Database Syst Rev. 2002; (1): CD001044. Go to original source...
- Schleich S, Papaioannou M, Baniahmad A, Matusch R. Extracts from Pygeum africanum and other ethnobotanical species with antiandrogenic activity. Planta Med. 2006; 72(9): 807-813. Go to original source... Go to PubMed...
- Tůmová L. Léčivé rostliny v léčbě prostatických potíží. Prakt. lékáren. 2015; 11(2): 68-70.
- Pagano E, Laudato M, Griffo M, Capasso R. Phytotherapy of Benign Prostatic Hyperplasia. A Minireview. Phytotherapy Research 2014; 28(7): 949-955. Go to original source... Go to PubMed...
- Buck AC, Cox R, Rees RW, Ebeling L, John A. Treatment of outflow tract obstruction due to benign prostatic hyperplasia with the pollen extract, cernilton. A double-blind, placebo-controlled study. British Journal of Urology 1990; 66: 398-404. Go to original source... Go to PubMed...
- Kroeger N, Belldegrun AS, Pantuck AJ. Pomegranate Extracts in the Management of Men's Urologic Health: Scientific Rationale and Preclinical and Clinical Data. Evidence-Based Complementary and Alternative Medicine 2013; 2013: 1-9. Go to original source...
- Atawia RT. Modulatory effect of silymarin on inflammatory mediators in experimentally induced benign prostatic hyperplasia: emphasis on PTEN, HIF-1?, and NF-?b. Naunyn-Schmiedeberg's Archives of Pharmacology 2014; 387(12): 1131-1140 Go to original source... Go to PubMed...
- Lucci P, Pacetti D, Loizzo MR, Frega NG, et al. Punica granatum cv. Dente di Cavallo seed ethanolic extract: antioxidant and antiproliferative activities. Food Chemistry 2015; 167: 475-483. Go to original source... Go to PubMed...